Carlyle joins Warburg as investor in Duravant, Linden preps 2022 sale of Evolution Research Group

Busted processes haunt investors in crowded M&A market.

29 October 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.